KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Change in Inventory (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Change in Inventory for 17 consecutive years, with -$71.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Inventory rose 59.43% to -$71.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $184.0 million, a 62.14% decrease, with the full-year FY2025 number at $184.0 million, down 62.14% from a year prior.
  • Change in Inventory was -$71.0 million for Q4 2025 at Bristol Myers Squibb, down from $90.0 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $282.0 million in Q1 2023 to a low of -$175.0 million in Q4 2024.
  • A 5-year average of $73.8 million and a median of $28.5 million in 2022 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: skyrocketed 28300.0% in 2023, then plummeted 188.83% in 2024.
  • Bristol Myers Squibb's Change in Inventory stood at $128.0 million in 2021, then crashed by 67.97% to $41.0 million in 2022, then soared by 380.49% to $197.0 million in 2023, then plummeted by 188.83% to -$175.0 million in 2024, then surged by 59.43% to -$71.0 million in 2025.
  • Per Business Quant, the three most recent readings for BMY's Change in Inventory are -$71.0 million (Q4 2025), $90.0 million (Q3 2025), and -$4.0 million (Q2 2025).